Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.


The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page


My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1984 2
1985 3
1986 2
1987 2
1988 2
1989 2
1990 2
1991 1
1992 7
1993 2
1994 2
1995 2
1996 1
1997 1
1998 2
1999 1
2000 2
2001 4
2002 2
2003 4
2004 6
2005 1
2006 5
2008 2
2009 1
2010 2
2011 9
2012 5
2013 5
2014 5
2015 6
2016 5
2017 5
2018 3
2019 2
2020 1
2021 5
2022 7
2023 8
2024 7

Text availability

Article attribute

Article type

Publication date

Search Results

123 results

Results by year

Filters applied: . Clear all
Page 1
MYC is a regulator of androgen receptor inhibition-induced metabolic requirements in prostate cancer.
Crowell PD, Giafaglione JM, Jones AE, Nunley NM, Hashimoto T, Delcourt AML, Petcherski A, Agrawal R, Bernard MJ, Diaz JA, Heering KY, Huang RR, Low JY, Matulionis N, Navone NM, Ye H, Zoubeidi A, Christofk HR, Rettig MB, Reiter RE, Haffner MC, Boutros PC, Shirihai OS, Divakaruni AS, Goldstein AS. Crowell PD, et al. Among authors: huang rr. Cell Rep. 2023 Oct 31;42(10):113221. doi: 10.1016/j.celrep.2023.113221. Epub 2023 Oct 9. Cell Rep. 2023. PMID: 37815914 Free article.
Tumour-induced immune modulation of sentinel lymph nodes.
Cochran AJ, Huang RR, Lee J, Itakura E, Leong SP, Essner R. Cochran AJ, et al. Among authors: huang rr. Nat Rev Immunol. 2006 Sep;6(9):659-70. doi: 10.1038/nri1919. Nat Rev Immunol. 2006. PMID: 16932751 Review.
Targeting Krebs-cycle-deficient renal cell carcinoma with Poly ADP-ribose polymerase inhibitors and low-dose alkylating chemotherapy.
Ueno D, Vasquez JC, Sule A, Liang J, van Doorn J, Sundaram R, Friedman S, Caliliw R, Ohtake S, Bao X, Li J, Ye H, Boyd K, Huang RR, Dodson J, Boutros P, Bindra RS, Shuch B. Ueno D, et al. Among authors: huang rr. Oncotarget. 2022 Sep 14;13:1054-1067. doi: 10.18632/oncotarget.28273. eCollection 2022. Oncotarget. 2022. PMID: 36128328 Free PMC article.
Targeting OXCT1-mediated ketone metabolism reprograms macrophages to promote antitumor immunity via CD8+ T cells in hepatocellular carcinoma.
Zhu CX, Yan K, Chen L, Huang RR, Bian ZH, Wei HR, Gu XM, Zhao YY, Liu MC, Suo CX, Li ZK, Yang ZY, Lu MQ, Hua XF, Li L, Zhao ZB, Sun LC, Zhang HF, Gao P, Lian ZX. Zhu CX, et al. Among authors: huang rr. J Hepatol. 2024 May 15:S0168-8278(24)00342-8. doi: 10.1016/j.jhep.2024.05.007. Online ahead of print. J Hepatol. 2024. PMID: 38759889
Accelerated treatment of breast cancer.
Vicini FA, Baglan KL, Kestin LL, Mitchell C, Chen PY, Frazier RC, Edmundson G, Goldstein NS, Benitez P, Huang RR, Martinez A. Vicini FA, et al. Among authors: huang rr. J Clin Oncol. 2001 Apr 1;19(7):1993-2001. doi: 10.1200/JCO.2001.19.7.1993. J Clin Oncol. 2001. PMID: 11283132 Review.
123 results